Aminopeptidase activity in renovascular hypertension

Medical Science Monitor

Volumn 9, Issue 1, 2003, Pages

  Prieto, Isabel ^a   Hermoso, Francisco ^a   De Gasparo, Marc ^b   Vargas, Félix ^c   Alba, Francisco ^d   Segarra, Ana B ^a   Banegas, Inmaculada ^a   Ramírez, Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Aminopeptidases; Two kidney one clip hypertension; Valsartan

Indexed keywords

5 OXOPROLYL PEPTIDASE; ALDOSTERONE; AMINOPEPTIDASE B; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ASPARTYL AMINOPEPTIDASE; CYSTYL AMINOPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMYL AMINOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; RENIN; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME METABOLISM; ENZYME SUBSTRATE; HALF LIFE TIME; HEART ATRIUM; HEART LEFT VENTRICLE; LUNG PARENCHYMA; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; RAT STRAIN; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

AMINOPEPTIDASES; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; DOWN-REGULATION; HEART ATRIA; HEART VENTRICLES; HYPERTENSION; HYPERTENSION, RENOVASCULAR; LUNG; MALE; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TETRAZOLES; VALINE;

EID: 0037277807     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Okamura T, Miyazaki M, Inagami T, Toda N: Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension, 1986; 8: 560-565
2. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev, 2000; 52: 11-34
3. Criscione L, Bradley WA, Bühlmayer P et al: Valsartan: Preclinical and clinical profile of an antihypertensive angiotensin-II antagonist. Card Drug Rev, 1995: 13: 230-250
4. Orfanos SE, Langleben D, Khoury J et al: Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans. Circulation, 1999; 99: 1593-1599
5. Nagano K, Toba K, Akishita M et al: Identification of arginine vasopressin mRNA in rat aortic smooth muscle cells. Biochem Biophys Res Commun, 1997; 231: 831-834
6. Jankowski M, Hajjar F. Al Kawas S et al: Rat heart: A site of oxytocin production and action. Proc Natl Acad Sci USA, 1998; 95: 14558-14563
7. Shi ZX, Xu W, Mergner WJ: Localization of thyrotropin-releasing hormone mRNA expression in the rat heart by in situ hybridization histochemistry. Pathobiology, 1996; 64: 314-319
8. Ramirez M, Prieto I, Martinez JM et al: Renal aminopeptidase activities in animal models of hypertension. Regul Pept, 1997; 72: 155-159
9. Wright JW, Harding JW: Important role for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev, 1997; 25: 96-124
10. Van Kats JP, de Lannoy LM, Jan Danser AH et al: Angiotensin II type 1 (ATI) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension, 1997; 30: 40-49
11. Barrett AJ, Rawlings ND, Woessner JF: Handbook of Proteolytic Enzymes, Academic Press, London, 1998; 994-1032
12. Li Q, Zhang J, Pfaffendorf M, van Zwieten PA: Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria. Br J Pharmacol, 1996; 118: 1653-1658
13. Shiota N, Miyazaki M, Okunishi H: Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension, 1992; 20: 168-174
14. Morishita R, Higaki J, Miyazaki M, Ogihara T: Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension, 1992; 19(2 Suppl): II62-II67
15. Turla MB, Thompson MM, Corjay MH, Owens GK: Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression. Circ Res, 1991; 68: 288-299